DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE214.10-1.35 (-0.63 %)
PREV CLOSE ( ) 215.45
OPEN PRICE ( ) 216.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9480
TODAY'S LOW / HIGH ( )213.50 218.20
52 WK LOW / HIGH ( )132.75 307.8
NSE214.37-1.24 (-0.58 %)
PREV CLOSE( ) 215.61
OPEN PRICE ( ) 215.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 229752
TODAY'S LOW / HIGH( ) 213.50 218.55
52 WK LOW / HIGH ( )133 307.98
( in Million)
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax-1222.60-545.90-42.50-650.301972.00
Adjustment3813.703924.603253.603125.403301.10
Changes In working Capital1438.30-377.30900.803163.501322.30
Cash Flow after changes in Working Capital4029.403001.404111.905638.606595.40
Cash Flow from Operating Activities3839.702659.503548.505126.605851.40
Cash Flow from Investing Activities-2295.20-4940.80-6185.30-3800.20-4417.40
Cash Flow from Financing Activities-221.502496.801303.70-110.40-977.80
Net Cash Inflow / Outflow1323.00215.50-1333.101216.00456.20
Opening Cash & Cash Equivalents1317.901102.402435.501219.40763.20
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent2640.901317.901102.402435.401219.40

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.